Новости
Какое-то описание
From May 2 to 6, the DEMEU team participated in the European oncology congress ESTRO 2025 in Vienna, as well as in the international Varian Summit, a Siemens Healthineers event focused on innovations in radiation therapy and cancer diagnostics.
We explored the latest technological advancements, exchanged experiences with colleagues from around the world, and discussed the prospects of introducing cutting-edge solutions into Kazakhstan’s healthcare system.
Ethos, Halcyon, HyperSight, AI-driven protocols, and personalized adaptive therapy — all of these are already shaping the future of cancer care.
We move forward together with the best.
From May 2 to 6, the DEMEU team participated in the European oncology congress ESTRO 2025 in Vienna, as well as in the international Varian Summit, a Siemens Healthineers event focused on innovations in radiation therapy and cancer diagnostics.
We explored the latest technological advancements, exchanged experiences with colleagues from around the world, and discussed the prospects of introducing cutting-edge solutions into Kazakhstan’s healthcare system.
Ethos, Halcyon, HyperSight, AI-driven protocols, and personalized adaptive therapy — all of these are already shaping the future of cancer care.
We move forward together with the best.
From May 2 to 6, the DEMEU team participated in the European oncology congress ESTRO 2025 in Vienna, as well as in the international Varian Summit, a Siemens Healthineers event focused on innovations in radiation therapy and cancer diagnostics.
We explored the latest technological advancements, exchanged experiences with colleagues from around the world, and discussed the prospects of introducing cutting-edge solutions into Kazakhstan’s healthcare system.
Ethos, Halcyon, HyperSight, AI-driven protocols, and personalized adaptive therapy — all of these are already shaping the future of cancer care.
We move forward together with the best.
From May 2 to 6, the DEMEU team participated in the European oncology congress ESTRO 2025 in Vienna, as well as in the international Varian Summit, a Siemens Healthineers event focused on innovations in radiation therapy and cancer diagnostics.
We explored the latest technological advancements, exchanged experiences with colleagues from around the world, and discussed the prospects of introducing cutting-edge solutions into Kazakhstan’s healthcare system.
Ethos, Halcyon, HyperSight, AI-driven protocols, and personalized adaptive therapy — all of these are already shaping the future of cancer care.
We move forward together with the best.
From May 2 to 6, the DEMEU team participated in the European oncology congress ESTRO 2025 in Vienna, as well as in the international Varian Summit, a Siemens Healthineers event focused on innovations in radiation therapy and cancer diagnostics.
We explored the latest technological advancements, exchanged experiences with colleagues from around the world, and discussed the prospects of introducing cutting-edge solutions into Kazakhstan’s healthcare system.
Ethos, Halcyon, HyperSight, AI-driven protocols, and personalized adaptive therapy — all of these are already shaping the future of cancer care.
We move forward together with the best.
On April 8–9, 2025, the Central Asian Lung Cancer Forum was held in Almaty under the theme "Current Issues in the Diagnosis and Treatment of Lung Cancer", dedicated to the 95th anniversary of the Asfendiyarov Kazakh National Medical University.
DEMEU served as a gold sponsor of the event, alongside our strategic partners — Varian and Siemens Healthineers.
During the forum, experts from Kazakhstan, Central Asia, and neighboring countries discussed the latest achievements in lung cancer diagnostics, treatment, and radiotherapy. This is an important platform for sharing experience and strengthening cooperation among specialists from different countries.
On September 19–20, DEMEU presented its solutions at the National Laboratory Diagnostics Forum NatForLab 2024, held in Astana. This is a key event for medical professionals and laboratory diagnostics specialists, where the latest advancements and cutting-edge healthcare technologies are discussed.
At the forum, the company showcased biochemical analyzers and other advanced laboratory solutions, demonstrating high standards and quality equipment that enhance diagnostic processes.
Participation in NatForLab 2024 enabled us to strengthen our position in the medical equipment market and establish new partnerships — reaffirming our mission to provide Kazakhstani institutions with modern and reliable medical solutions.
Наши бренды
Благодарим каждого члена нашей команды за их усердную работу в достижении общей цели. Мы рады, что можем быть частью развития медицинской технологии и с нетерпением ждем новых возможностей и достижений в будущем!